Chemical inhibitors of Ces6 can operate through various mechanisms to achieve functional inhibition. Proton pump inhibitors such as esomeprazole, omeprazole, pantoprazole, lansoprazole, rabeprazole, dexlansoprazole, and vonoprazan can alter the organellar pH balance, creating an environment less conducive to the stability or activity of Ces6. These inhibitors primarily target the acidic compartments within cells, and by increasing the pH, they can disrupt the finely-tuned acidic conditions that Ces6 requires for optimal enzymatic activity. For instance, Ces6, being a carboxylesterase, may exhibit a pH-dependent conformational state that is crucial for its catalytic function. Alterations in the pH of its surroundings can therefore lead to a decrease in its activity by hindering substrate binding or catalysis.
Furthermore, the modulation of oxidative stress within the cellular environment presents another route through which Ces6 activity can be indirectly inhibited. Allopurinol, febuxostat, and topiroxostat inhibit xanthine oxidase, an enzyme that contributes to the generation of reactive oxygen species (ROS). By reducing the levels of ROS, these chemicals can protect Ces6 from oxidative damage, which might otherwise lead to the modification of essential amino acid residues or the disruption of its tertiary structure, culminating in a loss of enzymatic activity. Additionally, tiopronin and glutathione serve as thiol agents and antioxidants, respectively, which can preserve the functional integrity of Ces6. They can maintain the redox state that Ces6 depends on for its activity, by either participating in thiol-disulfide exchanges or scavenging free radicals, preventing oxidative stress-mediated inhibition of the protein's enzymatic function. Through these distinct but converging pathways, these chemicals collectively contribute to the inhibition of Ces6 activity within the cell.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Similar to esomeprazole, it inhibits gastric proton pumps potentially altering organellar pH and indirectly affecting Ces6 stability and function. | ||||||
Pantoprazole | 102625-70-7 | sc-204830 sc-204830A | 100 mg 500 mg | $89.00 $255.00 | 2 | |
Proton pump inhibitor that could indirectly lead to an altered pH environment, potentially inhibiting Ces6 by affecting its pH-dependent stability. | ||||||
Lansoprazole | 103577-45-3 | sc-203101 sc-203101A | 500 mg 1 g | $59.00 $176.00 | 6 | |
By inhibiting proton pumps, it could modify the pH environment of Ces6, potentially leading to a reduction in its enzymatic activity. | ||||||
Rabeprazole | 117976-89-3 | sc-204872 sc-204872A | 10 mg 25 mg | $349.00 $620.00 | 2 | |
Affects proton pumps and could alter intracellular compartments' pH, possibly inhibiting Ces6 by impacting its optimal pH range. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Xanthine oxidase inhibitor that could reduce reactive oxygen species production, potentially protecting Ces6 from oxidative inactivation. | ||||||
Febuxostat | 144060-53-7 | sc-207680 | 10 mg | $168.00 | 3 | |
Inhibits xanthine oxidase, potentially decreasing oxidative stress, which could protect Ces6 from oxidative damage and inhibition. | ||||||
Glutathione, reduced | 70-18-8 | sc-29094 sc-29094A | 10 g 1 kg | $82.00 $2091.00 | 8 | |
Acts as an antioxidant, potentially protecting Ces6 from oxidative stress and maintaining its enzymatic activity. | ||||||